gSpin Technologies Accelerates MRI Innovation Through Mayo Clinic, MIPS, and the Global Radiology Community

gSpin Technologies is entering an exciting phase of growth, validation, and clinical engagement as we work to advance next-generation MRI RF coil technology for radiology, medical imaging, and clinical research.
 

Over the past several months, gSpin has reached two important milestones: joining the Mayo Clinic Berg Innovation Exchange Waypoints Program and securing support through the Maryland Industrial Partnerships (MIPS) program for independent MRI validation. At the same time, we are preparing to engage with the broader MRI and radiology communities through ISMRM, RSNA, and potentially MEDTECH.
 

Together, these activities reflect an important transition for gSpin: moving our RF coil technology from promising engineering results toward independent validation, clinical collaboration, and adoption by researchers and healthcare institutions.
 

Working With the Mayo Clinic Innovation Ecosystem

gSpin Technologies was recently invited to participate in the Mayo Clinic Berg Innovation Exchange Waypoints Program, a focused three-month engagement designed to connect selected innovators with Mayo Clinic clinicians, subject-matter experts, resources, and clinical insight.
 

For gSpin, this is particularly valuable because the development of new MRI technology requires much more than improvements on the engineering bench. Successful innovation must ultimately address the needs of radiologists, MRI physicists, clinical researchers, technologists, and healthcare systems.
 

Through the Waypoints Program, gSpin is exploring how its technology can address meaningful clinical and operational challenges and identify potential pathways for collaboration within the Mayo Clinic ecosystem. The program is structured to help companies identify gaps and opportunities, refine priorities, and connect with appropriate Mayo Clinic stakeholders.
 

For a company developing technology around MRI RF coils and magnetic resonance imaging, those conversations are essential. Better MRI performance can ultimately translate into opportunities for improved image quality, faster imaging, more efficient research protocols, and better utilization of expensive MRI infrastructure. MIPS Support Moves Independent MRI Validation Forward. At the same time, gSpin has reached another major milestone through the Maryland Industrial Partnerships (MIPS) program.
 

The MIPS agreement supporting gSpin's work became effective August 1, 2026. MIPS was established to facilitate commercially driven cooperative research between Maryland companies and university researchers.

Under the project, gSpin is working with the University of Maryland Baltimore's Center for Advanced Imaging Research (UMB CAIR) on independent validation of its technology on a 3T Bruker MRI system, with Dr. Thomas Ernst, Director of UMB CAIR, serving as Principal Investigator. Internal project materials describe the overall effort as a $123,000 MIPS-funded project beginning in August 2026.
 

This represents an important step for gSpin. Independent testing in a leading academic imaging environment provides an opportunity to evaluate the performance of gSpin's RF coil technology outside of our own laboratory and under conditions relevant to the MRI research and radiology communities. For clinical researchers using RF coils, reproducible performance matters. Signal-to-noise ratio, imaging speed, spatial resolution, coil configuration, field strength, workflow, and compatibility with existing MRI platforms can all influence the quality and practicality of an imaging study.
 

The MIPS-supported work is therefore not simply another engineering milestone. It is part of the process of building the independent evidence required for broader scientific and clinical adoption.
 

Preparing for ISMRM: Connecting With the MRI Research Community

As validation progresses, gSpin is also preparing to increase its engagement with the global magnetic resonance community, including ISMRM — the International Society for Magnetic Resonance in Medicine. ISMRM brings together many of the people who understand the importance of RF coil performance most deeply: MRI physicists, radiologists, engineers, pulse-sequence developers, imaging scientists, and clinical researchers.

For researchers working with MRI RF coils, improvements in RF performance can have implications across numerous areas of magnetic resonance research, from neuroimaging and musculoskeletal imaging to oncology, cardiovascular imaging, metabolic imaging, and quantitative MRI.
 

gSpin looks forward to discussing how new approaches to RF coil design and MRI signal performance could complement advances in sequences, reconstruction, artificial intelligence, and scanner hardware.

Looking Ahead to RSNA and the Radiology Community.
We are also preparing for RSNA, one of the world's most important gatherings for radiology and medical imaging.

While ISMRM provides an opportunity to engage deeply with the scientific and engineering side of magnetic resonance, RSNA connects innovation with the broader clinical environment in which MRI is ultimately used.
 

That means conversations with radiologists, imaging departments, clinical researchers, hospitals, academic medical centers, and MRI technology companies about a fundamental question: How can better RF coil technology help MRI systems produce more useful imaging while improving the economics and efficiency of the scan? MRI continues to advance rapidly through artificial intelligence, reconstruction techniques, new pulse sequences, and increasingly sophisticated scanner platforms. But the RF coil remains one of the critical interfaces between the MRI system and the signal researchers and clinicians are trying to measure. Improving that interface has the potential to create benefits throughout the imaging chain.

Expanding the Conversation at MEDTECH

gSpin is also considering participation in MEDTECH, extending these conversations beyond the core MRI research community to the broader medical technology ecosystem. That broader audience is increasingly important. Translating an innovation from an academic or engineering environment into routine clinical use requires collaboration among researchers, clinicians, medical-device companies, healthcare institutions, manufacturers, investors, and commercialization partners.  Our growing engagement with Mayo Clinic, UMB CAIR, MIPS, and the MRI community is helping gSpin build those connections.

From RF Coil Innovation to Clinical Impact

The common thread across these activities is validation.

gSpin's goal is not simply to develop another MRI component. We are working to demonstrate that advances in RF coil technology can provide measurable value to the people conducting MRI research and delivering diagnostic imaging.

That journey increasingly brings together three communities: MRI researchers, who need high-performance RF coils and reliable signal for demanding experiments. Radiologists and clinical researchers, who need imaging technology capable of producing clinically meaningful information efficiently.
 

MRI manufacturers and healthcare institutions, which need innovations that can integrate with existing systems and deliver practical economic and operational value.

Participation in the Mayo Clinic Berg Innovation Exchange Waypoints Program provides access to clinical perspectives. The MIPS-supported collaboration with UMB CAIR provides an independent pathway for technical validation.
And our preparations for ISMRM, RSNA, and potentially MEDTECH will give us an opportunity to share what we are learning with the broader radiology, MRI, and medical imaging communities.

It is an exciting period for gSpin Technologies—and an important step toward translating advanced RF coil technology into tools that can support the next generation of MRI research and clinical imaging.